Wenyan Lü

4.3k total citations
66 papers, 2.9k citations indexed

About

Wenyan Lü is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Wenyan Lü has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Wenyan Lü's work include Wnt/β-catenin signaling in development and cancer (20 papers), Cancer-related gene regulation (11 papers) and Alzheimer's disease research and treatments (7 papers). Wenyan Lü is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (20 papers), Cancer-related gene regulation (11 papers) and Alzheimer's disease research and treatments (7 papers). Wenyan Lü collaborates with scholars based in United States, China and Germany. Wenyan Lü's co-authors include Yonghe Li, Guojun Bu, Cuihong Lin, Gary A. Piazza, H. Drexler, Thomas J. Kelly, Sanjay Vashee, Johannes C. Walter, Adam B. Keeton and Heather N. Tinsley and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Genes & Development.

In The Last Decade

Wenyan Lü

62 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyan Lü United States 30 1.8k 473 439 398 339 66 2.9k
Kai Mao China 31 1.4k 0.8× 351 0.7× 237 0.5× 453 1.1× 374 1.1× 86 2.8k
Fumi Takahashi‐Yanaga Japan 32 2.1k 1.2× 639 1.4× 806 1.8× 319 0.8× 309 0.9× 89 3.3k
Riikka Kivelä Finland 29 1.8k 1.0× 477 1.0× 638 1.5× 330 0.8× 306 0.9× 58 2.9k
Iván P. Uray United States 20 1.3k 0.7× 434 0.9× 475 1.1× 129 0.3× 267 0.8× 40 2.3k
Lin Xu United States 29 1.7k 1.0× 257 0.5× 472 1.1× 235 0.6× 295 0.9× 143 2.6k
Whaseon Lee‐Kwon United States 28 1.6k 0.9× 377 0.8× 156 0.4× 371 0.9× 251 0.7× 56 2.5k
Jianjian Shi United States 26 1.4k 0.8× 349 0.7× 577 1.3× 364 0.9× 240 0.7× 38 2.4k
William S. Chen United States 17 2.6k 1.4× 729 1.5× 159 0.4× 326 0.8× 413 1.2× 25 3.6k
Xiaojun Zhu China 25 1.9k 1.1× 204 0.4× 258 0.6× 242 0.6× 292 0.9× 58 2.5k
Jingyi Gong United States 20 1.0k 0.6× 451 1.0× 443 1.0× 293 0.7× 146 0.4× 35 2.3k

Countries citing papers authored by Wenyan Lü

Since Specialization
Citations

This map shows the geographic impact of Wenyan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Lü more than expected).

Fields of papers citing papers by Wenyan Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Lü. The network helps show where Wenyan Lü may publish in the future.

Co-authorship network of co-authors of Wenyan Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Lü. A scholar is included among the top collaborators of Wenyan Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Lü. Wenyan Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Yasuteru, Hu Wang, Michael G. Heckman, et al.. (2025). Impact of APOE on cerebrovascular lipid profile in Alzheimer’s disease. Acta Neuropathologica. 150(1). 39–39.
2.
Yu, Hua, Lydia K. Nyasae, Wenyan Lü, et al.. (2025). Development of a Dihydrofolate Reductase Selection System for Saccharomyces boulardii. International Journal of Molecular Sciences. 26(5). 2073–2073.
3.
Chen, Yan, Yu Ye, Wenyan Lü, et al.. (2025). Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment. Biomaterials. 324. 123497–123497. 4 indexed citations
4.
Trushin, Sergey, Thi Kim Oanh Nguyen, Su-Youne Chang, et al.. (2025). Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease. EBioMedicine. 120. 105924–105924.
5.
Yan, Chen, et al.. (2024). Metformin promotes the survival of random skin flaps via the activation of Nrf2/HO-1 signaling. Chemico-Biological Interactions. 401. 111188–111188. 4 indexed citations
6.
Inoue, Yasuteru, Yingxue Ren, Shuwen Zhang, et al.. (2024). A novel histone deacetylase inhibitor W2A-16 improves the barrier integrity in brain vascular endothelial cells. Frontiers in Cellular Neuroscience. 18. 1368018–1368018. 3 indexed citations
7.
Lü, Wenyan, Francis Shue, Aishe Kurti, et al.. (2024). Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease. Neurobiology of Aging. 145. 13–23. 1 indexed citations
8.
Cao, Xiangyu, Liang Chen, Jianyun Chen, et al.. (2023). Seismic damage identification of high arch dams based on an unsupervised deep learning approach. Soil Dynamics and Earthquake Engineering. 168. 107834–107834. 23 indexed citations
9.
Xiong, Erhui, Hongli Liu, Wenyan Lü, et al.. (2023). WGCNA and transcriptome profiling reveal hub genes for key development stage seed size/oil content between wild and cultivated soybean. BMC Genomics. 24(1). 494–494. 16 indexed citations
10.
Wang, Na, Jing Zhao, Yingxue Ren, et al.. (2022). Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer’s Disease. Molecular Neurobiology. 60(1). 26–35. 8 indexed citations
11.
Londoño-Joshi, Angelina I., Rebecca C. Arend, Wenyan Lü, et al.. (2014). Effect of Niclosamide on Basal-like Breast Cancers. Molecular Cancer Therapeutics. 13(4). 800–811. 72 indexed citations
12.
Lin, Cuihong, Wenyan Lü, Wei Zhang, et al.. (2013). The C-Terminal Region Mesd Peptide Mimics Full-Length Mesd and Acts as an Inhibitor of Wnt/β-Catenin Signaling in Cancer Cells. PLoS ONE. 8(2). e58102–e58102. 12 indexed citations
13.
Lü, Wenyan, Cuihong Lin, Michael J. Roberts, et al.. (2011). Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway. PLoS ONE. 6(12). e29290–e29290. 184 indexed citations
14.
Lü, Wenyan, Heather N. Tinsley, Adam B. Keeton, et al.. (2008). Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation. European Journal of Pharmacology. 602(1). 8–14. 94 indexed citations
15.
Lü, Wenyan, Kyung-Ah Kim, Jianzhong Liu, et al.. (2008). R‐spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression. FEBS Letters. 582(5). 643–650. 65 indexed citations
16.
Li, Yonghe, Wenyan Lü, Xi He, Alan L. Schwartz, & Guojun Bu. (2004). LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution. Oncogene. 23(56). 9129–9135. 70 indexed citations
17.
Vashee, Sanjay, et al.. (2003). Sequence-independent DNA binding and replication initiation by the human origin recognition complex. Genes & Development. 17(15). 1894–1908. 239 indexed citations
18.
Li, Yonghe, Wenyan Lü, & Guojun Bu. (2003). Essential role of the low density lipoprotein receptor‐related protein in vascular smooth muscle cell migration. FEBS Letters. 555(2). 346–350. 35 indexed citations
19.
Tamura, Tetsutaro, et al.. (2000). Specificity of Tunel Method Depends on Duration of Fixation. Biotechnic & Histochemistry. 75(4). 197–200. 18 indexed citations
20.
Lindpaintner, Klaus, et al.. (1993). Selective Activation of Cardiac Angiotensinogen Gene Expression in Post-infarction Ventricular Remodeling in the Rat. Journal of Molecular and Cellular Cardiology. 25(2). 133–143. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Mao Breakdown of academic impact, for papers by Fumi Takahashi‐Yanaga Breakdown of academic impact, for papers by Riikka Kivelä Breakdown of academic impact, for papers by Iván P. Uray Breakdown of academic impact, for papers by Lin Xu Breakdown of academic impact, for papers by Whaseon Lee‐Kwon Breakdown of academic impact, for papers by Jianjian Shi Breakdown of academic impact, for papers by William S. Chen Breakdown of academic impact, for papers by Xiaojun Zhu Breakdown of academic impact, for papers by Jingyi Gong
Rankless by CCL
2026